Anna Lladó

962 total citations
19 papers, 760 citations indexed

About

Anna Lladó is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Anna Lladó has authored 19 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Anna Lladó's work include Cellular transport and secretion (3 papers), Cellular Mechanics and Interactions (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Anna Lladó is often cited by papers focused on Cellular transport and secretion (3 papers), Cellular Mechanics and Interactions (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Anna Lladó collaborates with scholars based in Spain, Switzerland and Italy. Anna Lladó's co-authors include Francesc Tebar, Carlos Enrich, Luca Gianni, Erik Schäffer, Francesco Ricci, Tania Patiño, Alessandro Porchetta, Samuel Sánchez, Anita Jannasch and David Cameron and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Anna Lladó

19 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lladó Spain 13 284 266 154 130 123 19 760
Jennifer Mataraza United States 14 330 1.2× 662 2.5× 265 1.7× 32 0.2× 186 1.5× 24 1.4k
Andrew J. Loza United States 11 289 1.0× 378 1.4× 147 1.0× 45 0.3× 280 2.3× 22 980
James Fick United States 10 127 0.4× 301 1.1× 395 2.6× 35 0.3× 47 0.4× 16 864
Yunsong Zhang China 11 196 0.7× 398 1.5× 127 0.8× 24 0.2× 126 1.0× 18 689
Yuqiang Fang China 12 336 1.2× 390 1.5× 34 0.2× 45 0.3× 63 0.5× 23 895
Hayri E. Balcıoğlu Netherlands 16 331 1.2× 316 1.2× 266 1.7× 24 0.2× 461 3.7× 29 1.1k
S. Laura Chang United States 15 246 0.9× 202 0.8× 86 0.6× 77 0.6× 52 0.4× 24 763
Olga Ilina Netherlands 11 531 1.9× 408 1.5× 484 3.1× 29 0.2× 615 5.0× 13 1.4k
Avinoam Bar‐Zion United States 14 71 0.3× 263 1.0× 489 3.2× 106 0.8× 31 0.3× 18 857
Weiyang Jin China 12 219 0.8× 320 1.2× 149 1.0× 54 0.4× 254 2.1× 19 922

Countries citing papers authored by Anna Lladó

Since Specialization
Citations

This map shows the geographic impact of Anna Lladó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lladó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lladó more than expected).

Fields of papers citing papers by Anna Lladó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lladó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lladó. The network helps show where Anna Lladó may publish in the future.

Co-authorship network of co-authors of Anna Lladó

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lladó. A scholar is included among the top collaborators of Anna Lladó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lladó. Anna Lladó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rivas, Elisa, Jenniffer Linares, Melissa Zwick, et al.. (2022). Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors. Nature Communications. 13(1). 5310–5310. 40 indexed citations
2.
Tosi, Sébastien, Anna Lladó, Lídia Bardia, et al.. (2021). AutoScanJ: A Suite of ImageJ Scripts for Intelligent Microscopy. Frontiers in Bioinformatics. 1. 10 indexed citations
3.
Garcia, Josep, J.M. Fernández-Pradas, Anna Lladó, et al.. (2020). The Combined Use of Gold Nanoparticles and Infrared Radiation Enables Cytosolic Protein Delivery. Chemistry - A European Journal. 27(14). 4670–4675. 5 indexed citations
4.
Cathomas, Richard, Julian Schardt, Miklos Pless, et al.. (2020). Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss Medical Weekly. 150(1920). w20223–w20223. 3 indexed citations
5.
Pittolo, Silvia, Hyojung Lee, Anna Lladó, et al.. (2019). Reversible silencing of endogenous receptors in intact brain tissue using 2-photon pharmacology. Proceedings of the National Academy of Sciences. 116(27). 13680–13689. 21 indexed citations
6.
Patiño, Tania, Alessandro Porchetta, Anita Jannasch, et al.. (2019). Self-Sensing Enzyme-Powered Micromotors Equipped with pH-Responsive DNA Nanoswitches. Nano Letters. 19(6). 3440–3447. 154 indexed citations
7.
Ivanova, Saška, et al.. (2019). Autophagy-induced senescence is regulated by p38α signaling. Cell Death and Disease. 10(6). 376–376. 68 indexed citations
9.
Tejeda‐Montes, Esther, Maxime Cazorla, Katherine Smith, et al.. (2013). Fabrication of hierarchical micro–nanotopographies for cell attachment studies. Nanotechnology. 24(25). 255305–255305. 36 indexed citations
10.
Gelabert‐Baldrich, Mariona, David Soriano‐Castell, Anna Lladó, et al.. (2011). Rac1 and Calmodulin Interactions Modulate Dynamics of ARF6‐Dependent Endocytosis. Traffic. 12(12). 1879–1896. 24 indexed citations
12.
Lladó, Anna, et al.. (2008). Calmodulin modulates H-Ras mediated Raf-1 activation. Cellular Signalling. 20(6). 1092–1103. 16 indexed citations
13.
Lladó, Anna, Paul Timpson, Sandra Vilà de Muga, et al.. (2007). Protein Kinase Cδ and Calmodulin Regulate Epidermal Growth Factor Receptor Recycling from Early Endosomes through Arp2/3 Complex and Cortactin. Molecular Biology of the Cell. 19(1). 17–29. 41 indexed citations
14.
Sessa, Cristiana, Antonella Perotti, Anna Lladó, et al.. (2007). Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule. Annals of Oncology. 18(9). 1548–1553. 37 indexed citations
15.
Sessa, Cristiana, Lucia Viganò, Giacomo Grasselli, et al.. (2006). Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing. European Journal of Cancer. 42(2). 171–178. 27 indexed citations
16.
Quintana, Luís F., Anna Lladó, Montserrat Butjosa, et al.. (2006). [Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].. PubMed. 26(4). 486–8. 2 indexed citations
17.
Sessa, Cristiana, Antonella Perotti, Emanuela Salvatorelli, et al.. (2004). Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin. European Journal of Cancer. 40(4). 563–570. 9 indexed citations
18.
Lladó, Anna, et al.. (2004). Protein KinaseCδ-Calmodulin Crosstalk Regulates Epidermal Growth Factor Receptor Exit from Early Endosomes. Molecular Biology of the Cell. 15(11). 4877–4891. 35 indexed citations
19.
Tebar, Francesc, Anna Lladó, & Carlos Enrich. (2002). Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC. FEBS Letters. 517(1-3). 206–210. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026